EMERYVILLE, Calif.--(BUSINESS WIRE)--Ansa Biotechnologies, Inc., a pioneer of next-generation DNA synthesis, today announced that it has synthesized and delivered complex clonal DNA sequences to ...

New proprietary assembly technology pairs with groundbreaking complex DNA synthesis platform to deliver sequence-perfect clonal DNA as long as 5 kb EMERYVILLE, Calif., November 12, 2024--(BUSINESS ...

BERKELEY, Calif.--(BUSINESS WIRE)--Ansa Biotechnologies today announced that it has raised $7.9 million in an oversubscribed Seed round of funding led by Horizons Ventures, with participation from ...

Genetic medicines R&D is making strides with more complex DNA molecules. While these long sequences of synthetic DNA are key for developing gene and cell therapies as well as antibodies and other ...